Study title: Comparative bioavailability and kinetics of Konakion MM: Ro 01-6722/122, oral and parenteral in infants suffering from chronic cholestasis
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Digestive System Diseases [C06] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: PHYTOMENADION | |||||
ATC code: B02BA01 | |||||
Document link: | |||||
Document date: | |||||
Study number: B-159'050 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | Y | - | - | - |